Variación en el cuidado de pacientes con Enfermedad Inflamatoria Intestinal (EII): resultado de una encuesta.

Saved in:

Bibliographic Details
Title:	Variación en el cuidado de pacientes con Enfermedad Inflamatoria Intestinal (EII): resultado de una encuesta.
Alternate Title:	Survey results regarding variations in care of patients with inflammatory bowel disease.
Authors:	Juliao Baños, Fabián^1,2 fabianjuliao@hotmail.com, Agudelo Zapata, Yineth³, Yepes Delgado, Carlos^4,5
Source:	Revista Colombiana de Gastroenterología. ene-mar2014, Vol. 29 Issue 1, p11-18. 8p.
Abstract (English):	Objectives: The quality of care of our patients with inflammatory bowel disease (IBD) is the principal mechanism through which we can offer an appropriate level of health care for our population. Therefore, it is important to determine variations in care provided for patients by specialists with expertise in the management of IBD in Colombia. Methods: This is a descriptive statistical analysis of responses to a survey with 13 questions related to quality of care provided to patients with IBD. The survey was conducted in 2011 among specialists who are interested in the management of patients with IBD. Results: Fifty seven gastroenterologists and coloproctologists answered all 13 questionnaire questions. Among the most interesting results is the fact that 44 % of the respondents use topical 5-ASA drugs as monotherapy for treatment of mild ulcerative proctitis. 30% use correct doses of azathioprine (2.0 to 2.5 mg / kg). Only 47 % of these specialists prefer to start with top down biological therapy in patients with fistulizing Crohn's disease (CD). Fifty four percent vaccinate their patients with IBD prior to the start of immunosuppressive therapy. Sixty seven percent think that patients with CD should suspend smoking, but 21% do not give patients any recommendation about smoking. Only 54 % of respondents screen for osteoporosis in individuals with IBD and chronic steroid use. Finally, 67% screen for colorectal cancer in patients with CD which is similar to the recommendations for ulcerative colitis (UC). Conclusion: Treatment and preventive care for patients with IBD varies greatly within our environment, this represents a great opportunity for continuous improvement in our daily practice. Greater adherence to guidelines and recommendations for proper management of our patients with IBD is required. [ABSTRACT FROM AUTHOR]
Abstract (Spanish):	Objetivos: determinar, en Colombia, la variación en el cuidado de pacientes con enfermedad inflamatoria intestinal (EII) entre especialistas con experiencia en el manejo de esta entidad. La calidad en el cuidado de nuestros pacientes con EII es el principal mecanismo a través del cual podemos ofrecer un nivel adecuado de atención en salud a nuestra población. Métodos: se realizó un análisis estadístico descriptivo con las respuestas obtenidas de una encuesta con 13 preguntas relacionadas con calidad en el cuidado de pacientes con EII realizada durante el año 2011 a especialistas con interés en el manejo de pacientes con EII. Resultados: cincuenta y siete especialistas en gastroenterología y coloproctología contestaron el cuestionario de 13 preguntas. Dentro de los resultados más interesantes tenemos que 44% de los encuestados utiliza medicamentos 5-ASA tópico como monoterapia para el tratamiento de proctitis ulcerativa leve. 30% utiliza dosis correcta de azatioprina (2,0-2,5 mg/kg). Solo 47% de los especialistas prefi eren la terapia biológica de inicio ("top down") en pacientes con Enfermedad de Crohn (EC) fistulizante. 54% realizan vacunación a sus pacientes con EII previo al inicio de terapia inmunosupresora. En cuanto al tabaquismo en EC, 67% consideran que deben suspenderlo pero 21% no dan recomendaciones al respecto. Solo 54% de los encuestados realizan tamizaje para osteoporosis en individuos con EII y uso crónico de esteroides. Por último, en cuanto a tamizaje de cáncer colorrectal en pacientes con EC, el 67% lo realiza similar a las recomendaciones para colitis ulcerativa (CU). Conclusión: existe una gran variabilidad en el manejo y en el cuidado preventivo de pacientes con EII en nuestro medio, esto representa una gran oportunidad para un mejoramiento continuo de nuestra práctica diaria. Es necesaria una mayor adherencia a las guías y recomendaciones internacionales por parte nuestra, para un adecuado manejo de los pacientes con EII. [ABSTRACT FROM AUTHOR]
	Copyright of Revista Colombiana de Gastroenterología is the property of Asociacion Colombiana de Gastroenterologia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	MedicLatina

Description
Abstract:	Objectives: The quality of care of our patients with inflammatory bowel disease (IBD) is the principal mechanism through which we can offer an appropriate level of health care for our population. Therefore, it is important to determine variations in care provided for patients by specialists with expertise in the management of IBD in Colombia. Methods: This is a descriptive statistical analysis of responses to a survey with 13 questions related to quality of care provided to patients with IBD. The survey was conducted in 2011 among specialists who are interested in the management of patients with IBD. Results: Fifty seven gastroenterologists and coloproctologists answered all 13 questionnaire questions. Among the most interesting results is the fact that 44 % of the respondents use topical 5-ASA drugs as monotherapy for treatment of mild ulcerative proctitis. 30% use correct doses of azathioprine (2.0 to 2.5 mg / kg). Only 47 % of these specialists prefer to start with top down biological therapy in patients with fistulizing Crohn's disease (CD). Fifty four percent vaccinate their patients with IBD prior to the start of immunosuppressive therapy. Sixty seven percent think that patients with CD should suspend smoking, but 21% do not give patients any recommendation about smoking. Only 54 % of respondents screen for osteoporosis in individuals with IBD and chronic steroid use. Finally, 67% screen for colorectal cancer in patients with CD which is similar to the recommendations for ulcerative colitis (UC). Conclusion: Treatment and preventive care for patients with IBD varies greatly within our environment, this represents a great opportunity for continuous improvement in our daily practice. Greater adherence to guidelines and recommendations for proper management of our patients with IBD is required. [ABSTRACT FROM AUTHOR]
ISSN:	01209957